Sign up to save your podcasts
Or
Share Global Collaboration: East - West Exchange to Learn from Each Other
Share to email
Share to Facebook
Share to X
Share to email
Share to Facebook
Share to X
Or
Global Collaboration: East - West Exchange to Learn from Each Other
Prof. Daisuke Yabe on East-West Diabetes Research and the Future of Stem Cell Therapy for Diabetes
Watch the full video on YouTube. In this episode of Diabetes Insights, Vivienne Parry speaks with Prof. Daisuke Yabe (Kyoto University) about why EASD has become one of the world's leading forums for diabetes research and collaboration.
The discussion explores how differences in diabetes phenotypes between Europe and East Asia are helping researchers better understand the disease, improve treatments and develop new scientific collaborations across continents.
Professor Yabe also discusses the exciting progress being made in regenerative medicine, including clinical trials using iPS cell-derived islet cells for people living with type 1 diabetes. He explains how this approach could help overcome donor shortages and bring scalable cell therapies closer to clinical practice.
Topics covered:
Featured speaker:
For more content from previous episodes, visit our podcast archive.
View all episodes
By EASD - European Association for the Study of DiabetesProf. Daisuke Yabe on East-West Diabetes Research and the Future of Stem Cell Therapy for Diabetes
Watch the full video on YouTube. In this episode of Diabetes Insights, Vivienne Parry speaks with Prof. Daisuke Yabe (Kyoto University) about why EASD has become one of the world's leading forums for diabetes research and collaboration.
The discussion explores how differences in diabetes phenotypes between Europe and East Asia are helping researchers better understand the disease, improve treatments and develop new scientific collaborations across continents.
Professor Yabe also discusses the exciting progress being made in regenerative medicine, including clinical trials using iPS cell-derived islet cells for people living with type 1 diabetes. He explains how this approach could help overcome donor shortages and bring scalable cell therapies closer to clinical practice.
Topics covered:
Featured speaker:
For more content from previous episodes, visit our podcast archive.